Can Fite Biopharma (CANF) Fades on Direct Offering

September 21, 2015 10:50 AM | 11 seconds read |
Can Fite Biopharma Ltd (NYSE MKT: CANF) shares declined 11.8% to $4.32 following announcement of a $9-million registered direct offering. Share volume was 211,000, compared to an all-day average of 57,000
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!